Adaptive Biotechnologies Corp.

📍 Seattle, United States🗓 Founded 2009👥 788 employees💰 Last funded 2016
Biotechnology🌐 adaptivebiotech.com
Website LinkedIn
Adaptive Biotechnologies is a pioneer and leader in immune-driven medicine that aims to improve people’s lives by learning from the wisdom of their adaptive immune systems. Adaptive’s proprietary immune profiling platform reveals and translates insights from our adaptive immune systems with unprecedented scale and precision. Working with drug developers, clinicians and academic researchers, we are applying these insights to develop products that will transform the way diseases -- such as cancer, autoimmune conditions, and infectious diseases -- are diagnosed and treated. For more information, please visit adaptivebiotech.com.
3
Total investors
1
Early stage
0
Mid stage
2
Late stage
2009
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
3
Investor activity2009–2016 · investors recorded per year
200912015120161
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Adaptive Biotechnologies Corp.?
Adaptive Biotechnologies Corp. has 3 investors on record on gritt.io, including 1 early-stage backers and 2 late-stage investors.
When did Adaptive Biotechnologies Corp. last raise funding?
The most recent investment in Adaptive Biotechnologies Corp. recorded on gritt.io was in 2016.
When was Adaptive Biotechnologies Corp. founded?
Adaptive Biotechnologies Corp. was founded in 2009.
What industry is Adaptive Biotechnologies Corp. in?
Adaptive Biotechnologies Corp. operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Adaptive Biotechnologies Corp. based?
Adaptive Biotechnologies Corp. is headquartered in Seattle, United States.